Chesley's Hypertensive Disorders in Pregnancy,
Edition 4
Edited by Robert N. Taylor, James M. Roberts, Gary F. Cunningham and Marshall D. Lindheimer, MD, FACP

Publication Date: 02 Sep 2014
Description

Chesley’s Hypertensive Disorders in Pregnancy continues its tradition as one of the beacons to guide the field of preeclampsia research, recognized for its uniqueness and utility. Hypertensive disorders remain one the major causes of maternal and fetal morbidity and death. It is also a leading cause of preterm birth now known to be a risk factor in remote cardiovascular disease. Despite this the hypertensive disorders remain marginally studied and management is often controversial.The fourth edition of Chesley’s Hypertensive Disorders in Pregnancy focuses on prediction, prevention, and management for clinicians, and is an essential reference text for clinical and basic investigators alike. Differing from other texts devoted to preeclampsia, it covers the whole gamut of high blood pressure, and not just preeclampsia.

Key Features

  • Features new chapters focusing on recent discoveries in areas such as fetal programming, genomics/proteomics, and angiogenesis
  • Includes extensive updates to chapters on epidemiology, etiological considerations, pathophysiology, prediction, prevention, and management
  • Discusses the emerging roles of metabolic syndrome and obesity and the increasing incidence of preeclampsia
  • Each section overseen by one of the editors; each chapter co-authored by one of the editors, ensuring coherence throughout book
About the author
Edited by Robert N. Taylor, Professor of Obstetrics and Gynecology and Assistant Dean for Student and Academic Affairs, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA; James M. Roberts, Senior Scientist, Magee Women’s Research Institute, Professor, Obstetrics, Gynecology, Reproductive Sciences, Epidemiology, and Clinical and Translational ResearchUniversity of Pittsburgh, Pittsburgh, PA, USA; Gary F. Cunningham, Professor and Beatrice and Miguel Elias Distinguished Chair in Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, USA and Marshall D. Lindheimer, MD, FACP, Professor Emeritus, Department of Obstetrics and Gynecology and Medicine, and the Committee on Clinical Pharmacology, The University of Chicago, IL, USA
Table of Contents
  • List of Contributors
  • Preface
    • Preface to the Second Edition
    • Comments Added to the Preface by Editors in 2008
    • Preface to the Fourth Edition
  • Chapter 1. Introduction, History, Controversies, and Definitions
    • History (Fig. 1.1)
    • Signs
    • Hypotheses and Rational Management
    • Prophylaxis
    • Classification of the Hypertensive Disorders in Pregnancy
    • Editors’ Update
    • Denouement
    • References
  • Chapter 2. The Clinical Spectrum of Preeclampsia
    • Introduction
    • Clinical Manifestations of Preeclampsia Syndrome
    • Differential Diagnosis
    • References
  • Chapter 3. Epidemiology of Pregnancy-Related Hypertension
    • Introduction
    • Definitions of the Hypertensive Disorders of Pregnancy
    • Prevalence of Hypertensive Disorders of Pregnancy
    • Risk Factors for Preeclampsia
    • First Birth and Other Placental Factors
    • Clinical Predictors
    • Natural History
    • Impact on Children
    • Critique of Studies
    • Conclusion
    • Acknowledgment
    • References
  • Chapter 4. Genetic Factors in the Etiology of Preeclampsia/Eclampsia
    • Dedication
    • Introduction
    • Biological Pathways of Preeclampsia
    • Types of Genetic Studies Conducted
    • A Genomics Approach to Preeclampsia
    • Essential Variables to Consider
    • High-Dimensional Biology
    • A Predictive Genetic Test
    • Pharmacogenomics
    • The Future of Preeclampsia Genetic Research
    • Conclusions
    • References
  • Chapter 5. The Placenta in Normal Pregnancy and Preeclampsia
    • Introduction
    • The Microanatomy of Normal Human Placentation
    • The Microanatomy of Abnormal Human Placentation in Preeclampsia
    • The Road to Preeclampsia
    • Oxygen Tension Regulates Human Cytotrophoblast Proliferation and Differentiation In Vitro
    • During Normal Pregnancy, Invasive Cytotrophoblasts Modulate their Adhesion Molecule Repertoire to Mimic That of Vascular Cells
    • In Preeclampsia, Invasive Cytotrophoblasts Fail to Switch their Adhesion Molecule Repertoire to Mimic That of Vascular Cells
    • The Pathological Consequences of Abnormal Cytotrophoblast Invasion and Failed Spiral Artery Remodeling
    • Novel Unbiased Approaches for Addressing the Complexities of the Preeclampsia Syndrome
    • Summary and Future Directions
    • Appendix Trophoblast Gene Expression in Normal Pregnancy and Preeclampsia
    • References
  • Chapter 6. Angiogenesis and Preeclampsia
    • Introduction
    • Placental Vascular Development in Health
    • Angiogenic Imbalance in Preeclampsia
    • Perspectives
    • References
  • Chapter 7. Metabolic Syndrome and Preeclampsia
    • Introduction
    • Metabolic Syndrome
    • Metabolic Syndrome and Cardiovascular Disease
    • Pregnancy-Induced Metabolic Changes
    • Preeclampsia and Metabolic Syndrome
    • Metabolic Syndrome: A Cause of Placental Dysfunction?
    • Summary and Perspectives
    • References
  • Chapter 8. Immunology of Normal Pregnancy and Preeclampsia
    • Introduction
    • Maternal Adaptation to a Foreign Fetus
    • Innate and Adaptive Immunity
    • Nature’s Transplant
    • Classical Two-Stage Model of Preeclampsia
    • Stage 1 Preeclampsia, Interface 1 and Maternal Immune Responses to Trophoblast
    • Stage 2 Preeclampsia and Interface 2
    • Endothelial Cells are Inflammatory Cells
    • Inflammation and the Integrated Stress Response
    • Widespread Implications of Vascular Inflammation
    • Cytokines, Chemokines, Growth Factors, Adipokines and Angiogenic Factors
    • Metabolism and Vascular Inflammation
    • Acute-Phase Response
    • Vascular Inflammation in Normal Pregnancy and Preeclampsia
    • The Continuum between Normal Pregnancy and Preeclampsia
    • Immunoregulation
    • T Regulatory Cells, Th17 and T-Cell Memory
    • Angiotensin II (Ang II), the Immune System and Preeclampsia
    • Systemic Immunoregulation in Normal Pregnancy and Preeclampsia
    • Acute Atherosis: A Second Inflammatory Lesion of Preeclampsia
    • The Role of the Placenta and Non-Placental Factors
    • Trophoblast Extracellular Vesicles
    • Maternal Predisposing Factors
    • Conclusions
    • References
  • Chapter 9. Endothelial Cell Dysfunction
    • Introduction
    • Part I: Endothelial Cell Function and Preeclampsia
    • Part II: Circulating Factors Induce Endothelial Cell Dysfunction
    • Part III: Oxidative Stress: A Point of Convergence for Endothelial Cell Dysfunction
    • Part IV: Clinical Trials
    • Part V: Speculations and Directions of Future Investigations
    • References
  • Chapter 10. Animal Models for Investigating Pathophysiological Mechanisms of Preeclampsia
    • Introduction
    • Models Used to Investigate Links between Placental Ischemia and Endothelial and Cardiovascular Dysfunction
    • Animal Models Used to Study Role of Angiogenic Factors (See also Chapter 6)
    • Models Used to Investigate the Role of Immune Mechanisms in Preeclampsia
    • Genetic Models
    • Summary
    • References
  • Chapter 11. Tests to Predict Preeclampsia
    • Introduction
    • Assessing the Quality of Tests to Predict Disease
    • Placental Perfusion and Vascular Resistance Dysfunction-Related Tests
    • Fetal and Placental Unit Endocrinology Dysfunction-Related Tests
    • Renal Dysfunction-Related Tests
    • Endothelial Dysfunction and Oxidant Stress-Related Tests
    • Other Tests
    • The Use of Combined Tests
    • Multivariable Prediction Models Derived from Combinations of Maternal Characteristics and Tests
    • Perspectives and Conclusions
    • Acknowledgement
    • References
  • Chapter 12. Prevention of Preeclampsia and Eclampsia
    • Introduction
    • Dietary Manipulations
    • Physical Activity
    • Diuretics and Antihypertensive Drugs
    • Antioxidant Vitamins
    • Antithrombotic Agents
    • Prevention of Eclampsia
    • Treatment for Eclampsia (See Chapter 20)
    • References
  • Chapter 13. Cerebrovascular Pathophysiology in Preeclampsia and Eclampsia
    • Introduction
    • Neuroanatomical Findings with Eclampsia
    • Neuroimaging in Eclampsia
    • Pathogenesis of Cerebral Manifestations in (PRE)Eclampsia
    • Eclampsia as Posterior Reversible Encephalopathy Syndrome (PRES)
    • Cerebral Blood Flow Autoregulation
    • Cerebral Blood Flow Autoregulation and Hemodynamics in Pregnancy
    • Mechanisms of Seizure During Pregnancy and Preeclampsia
    • Role of Circulating Factors in Eclampsia
    • Remote Cerebrovascular Health Following Preeclampsia and Eclampsia
    • References
  • Chapter 14. Cardiovascular Alterations in Normal and Preeclamptic Pregnancy
    • Introduction
    • Hemodynamics and Cardiac Function in Normal Pregnancy
    • Hemodynamics and Cardiac Function in Preeclampsia
    • Factors that May Explain Vascular Changes in pregnancy
    • Pregnancy-Associated Responses and the Assessment of Cardiovacular Disease Risk Later in Life
    • Summary
    • References
  • Chapter 15. The Renin-Angiotensin System, its Autoantibodies, and Body Fluid Volume in Preeclampsia
    • Introduction
    • Body Fluid Volumes
    • Plasma Volume in Normal Pregnancy and Preeclampsia
    • Concluding Perspectives
    • References
  • Chapter 16. The Kidney in Normal Pregnancy and Preeclampsia
    • Introduction
    • Renal Hemodynamics and Glomerular Filtration Rate During Normal Pregnancy
    • Osmoregulation in Normal Pregnancy
    • Renal Hemodynamics and Glomerular Filtration Rate in Preeclampsia
    • Renal Handling of Uric Acid
    • Renal Handling of Proteins
    • Renal Morphology in Pregnancy and Preeclampsia
    • References
  • Chapter 17. Platelets, Coagulation, and the Liver
    • Introduction
    • Platelets
    • Coagulation
    • The Liver in Preeclampsia
    • References
  • Chapter 18. Chronic Hypertension and Pregnancy
    • Introduction
    • Background
    • Specific Hypertensive Disorders
    • Management Principles
    • References
  • Chapter 19. Antihypertensive Treatment
    • Introduction
    • Goals of Antihypertensive Drug Therapy
    • General Principles in the Choice of Antihypertensive Agents
    • Fetal Safety and Drug Use in Pregnant Women
    • Choice of an Antihypertensive Drug for Use in Pregnancy
    • Drug Use While Breastfeeding
    • Evidence from Randomized Trials
    • Conclusion
    • References
  • Chapter 20. Clinical Management
    • Introduction
    • Preeclampsia
    • Eclampsia
    • Management of Severe Hypertension
    • Neuroprophylaxis – Prevention of Eclampsia
    • Delivery
    • Persistent Severe Postpartum Hypertension
    • References
  • Index
  • Color Plates
Book details
ISBN: 9780124078666
Page Count: 484
Retail Price : £110.00
  • Goldman et.al., Women and Health, 2e, 9780123849786, 2012, $159.95; 1e published in 2000
  • Gabbe, Normal and Problem Pregnancies, 6e, 9781437719352, 2012, $169.00, Saunders; 5e published in 2007
  • Gupta, Reproductive and Developmental Toxicology, 9780123820327, 02/2011, $250.00
  • Alpern et.al., Seldin & Giebisch’s The Kidney, 5e, Two-Volume Set, 9780123814623, 2012, $400.00; 4e published in 2007
  • Black, Hypertension, 2e: A Companion to Braunwald’s Heart Disease, 9781455737352, Saunders, 2012, $169.00, 466 pp.
Audience

Researchers and clinicians in OB/GYN, nephrology, and cardiology; as well as graduate students and post-doctoral fellows in physiology, renal, cardiovascular, and hypertension research